PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy. Yu M, Chen Z, Zhou Q, Zhang B, et al. J Hepatol 2022;77:140-151.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu M, Chen Z, Zhou Q, Zhang B, et al. PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy. J Hepatol 2022;77:140-151.
PMID: 35157958